Investigating physicians’ views on non-formulary prescribing: a qualitative study using the theoretical domains framework

被引:0
作者
Zachariah Nazar
Moza Al Hail
Samaher Al-Shaibi
Tarteel Ali Hussain
Nada Nabil Abdelkader
Abdulrouf Pallivalapila
Binny Thomas
Wessam El Kassem
Yolande Hanssens
Ahmed Mahfouz
Cristin Ryan
Derek Stewart
机构
[1] QU Health,College of Pharmacy
[2] Qatar University,Women’s Wellness and Research Center
[3] Hamad Medical Corporation,School of Pharmacy and Pharmaceutical Sciences
[4] Hamad Medical Corporation,Pharmacy department
[5] Trinity College Dublin,undefined
[6] Mohammed Al-Mana College for Medical Sciences,undefined
来源
International Journal of Clinical Pharmacy | 2023年 / 45卷
关键词
Attitude of health personnel; Behavior change; Clinical pharmacy; Drug safety; Formulary; Inappropriate prescribing; Qualitative research; Theoretical domains framework;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1424 / 1433
页数:9
相关论文
共 164 条
[1]  
Rosenau PV(2009)Pharmacy policy: a public health perspective on safety and cost Soc Work Public Health. 24 543-567
[2]  
Lal LS(1992)Drug formulary: The cornerstone of a managed pharmacy program J Pharm Pract 5 75-81
[3]  
Glasser JHUS(2009)Formulary management in the Department of Defense J Manag Care Pharm 15 133-146
[4]  
Bruzek RJ(2010)How P&T committees can be effective change agents: Part 1 Am J Pharm Benefits. 2 99-100
[5]  
Dullinger D(1997)Do prescribing formularies help GPs prescribe from a narrower range of drugs? A controlled trial of the introduction of prescribing formularies for NSAIDs Br J Gen Pract 47 810-814
[6]  
Trice S(2004)A bitter pill: formulary variability and the challenge to prescribing physicians J Am Board Fam Pract 17 401-407
[7]  
Devine J(1990)Drug formularies: myths-ln-formation Med Care 28 928-942
[8]  
Mistry H(2009)Change we can believe in: requiring better evidence for formulary coverage Am J Pharm Benefits 1 134-136
[9]  
Mora MW(2005)Principles for evidence-based drug formulary policy J Gen Intern Med 20 964-968
[10]  
Avery AJ(1997)Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions Soc Sci Med 45 535-544